GTC presented abstracts at ASH 2024
GTC’s posters from 2024 Convention of American Society of Hematology are now available to be downloaded. Please reach out with any questions.
Establishing a Distinct Cytokine Signature for Multiple Myeloma
Using Bone Marrow RNA and Peripheral Blood Cell-Free RNA (cfRNA)
Establishing Distinct Cytokine Signatures Differentiating between Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Chip Using Bone Marrow RNA or Cell-Free RNA (cfRNA)
Establishing Lymphoma Type-Specific Cytokine Signatures
Using Tissue-Based RNA or Peripheral Blood Cell-Free RNA (cfRNA)
Clonotype- naive Detection Of Clonality in Patients Suspected of Having Multiple Myeloma or Monoclonal Gammopathy Using Peripheral Blood Cell-Free RNA (cfRNA)
Read more Articles and News from GTC
Press Releases
GTC opens Houston laboratory, expanding national precision oncology network
New central U.S. location strengthens testing capacity and turnaround times while positioning GTC within the Texas Medical Center ecosystem HOUSTON — March 12, 2026 — Genomic
March 12, 2026 No Comments
January 7, 2026 No Comments
January 7, 2026 No Comments
January 7, 2026 No Comments
January 7, 2026 No Comments
January 7, 2026 No Comments